United States· US:59762-2858_6aeb23c4-3f3f-4966-829c-12e7e6ec91ef
EXEMESTANE
A exemestane product containing exemestane, registered in United States by Mylan Pharmaceuticals Inc.. The same ATC class is registered in 17 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Exemestane is registered in 17 of 19 countries.
Countries holding a registration under ATC L02BG06 (exemestane), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Exemestane · ATC L02BG06
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of exemestane costs, country by country.
Normalised to the WHO defined daily dose (25 mg), the median price runs from $1.43 in France to $3.32 in Switzerland — a ×2.3 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Exemestane · price per daily dose (25 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.32
- IT Italy$2.46
- FR France$1.43
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- EXEMESTANE
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- L02BG06
- ATC class
- Exemestane
- Defined daily dose
- 25 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11597622858130 TABLET, SUGAR COATED in 1 BOTTLE (59762-2858-1)
- ndc1159762-2858-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
236 interactions on record for exemestane.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Exemestane · interactions on record
236 records
- 1 severe
- 83 moderate
- 152 info
Most severe, free to view
- ThalidomideL04AX02severe
- TroglitazoneA10BG01moderate
- SulfinpyrazonB01AC12moderate
- FostamatinibB02BX09moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Exemestane in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayAromasinPfizer AS
- PolandSymexSymphar Sp. z o.o.
- United KingdomAromasin 25mg tabletsCST Pharma Ltd
- CzechiaAROMASINPfizer, spol. s r.o., Praha
- ItalyAROMASINMEDIFARM S.R.L.
- SpainAROMASIL 25 mg COMPRIMIDOS RECUBIERTOSPfizer S.L.
- FranceAROMASINE 25 mg, comprimé enrobéPFIZER HOLDING FRANCE
- GermanyAromasinPfizer Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Aromasin, Exemestan Accord
- Belgium · Aromasin, Exemestan Sandoz
- Bulgaria · Аромазин, Екземегратис
- Cyprus · Exedral
- Czechia · Aromasin, Astexana
- Germany · Aromasin, Exemestan 1 A Pharma
- Denmark · Aromasin, Exemestan Accord
- Estonia · Aromasin, Exemestane Accord
- Spain · Aromasil, Exemestano Aurovitas
- Finland · Aromasin, Exemestan Pfizer
- France · Aromasine, Exemestane Accord
- United Kingdom (Northern Ireland) · Aromasin, Exemestane
- Greece · Aromaplex, Aromasin
- Croatia · Aromasin, Eksemestan Jgl
- Hungary · Aromasin, Exemestane Pharmacenter
- Ireland · Aromasin, Exemestane Accord
- Iceland · Aromasin, Exemestan Actavis
- Italy · Aromasin, Axelta
- Lithuania · Aromasin, Exemestane Accord
- Luxembourg · Aromasin, Exemestan Ratiopharm
- Latvia · Exemestane Accord, Exemestane Sanoswiss
- Malta · Aromasin, Exedral 25
- Netherlands · Aromasin, Exemestaan Accord
- Norway · Aromasin, Exemestan Sandoz
- Poland · Astexana, Glandex
- Portugal · Aromasin, Exemestano Accord
- Romania · Aromasin, Exemestan Accord
- Sweden · Exemestan Actavis, Exemestan Sandoz
- Slovenia · Aromasin
- Slovakia · Aromasin, Astexana
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df65116e-41c0-41b7-8ab4-e3d2976fc64c GET /v1/drugs/df65116e-41c0-41b7-8ab4-e3d2976fc64c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "25",
"substance": "EXEMESTANE",
"productndc": "59762-2858",
"dosage_form": "TABLET, SUGAR COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA020753",
"marketing_category": "NDA AUTHORIZED GENERIC"
}See everything about exemestane.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.